Actavia Life Sciences, Inc.
RASP · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $1 | $19 | $75 | $2 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $47 | $7 | $21 | $0 |
| Inventory | $0 | -$7 | -$21 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $49 | $26 | $96 | $37 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $49 | $26 | $96 | $37 |
| Liabilities | – | – | – | – |
| Payables | $1,504 | $1,514 | $960 | $1,482 |
| Short-Term Debt | $304 | $226 | $211 | $216 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | -$1,514 | $0 | $0 |
| Other Curr. Liab. | $423 | $1,904 | $2 | $0 |
| Total Curr. Liab. | $2,230 | $2,130 | $2,052 | $2,012 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $2,230 | $2,130 | $2,052 | $2,012 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $772 | $772 | $772 | $772 |
| Retained Earnings | -$28,907 | -$28,811 | -$28,664 | -$28,605 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$2,182 | -$2,104 | -$1,956 | -$1,975 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $49 | $26 | $96 | $37 |
| Net Debt | $303 | $207 | $136 | $213 |